| |
|
|
|
Caladrius Biosciences Inc.  
|
|
2.85 -0.05 (-0.02%) |
06-18 16:00 |
|
Open: |
2.87 |
Pre close: |
2.9 |
Target:
|
3.48
|
|
High: |
2.93 |
Low: |
2.85 |
Resistance:
|
2.98
3.18
|
|
Volume: |
29,609 |
Market Cap: |
30M |
Support:
|
2.65
2.20
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.86
 |
MACD |
MACD(12,26):
|
-0.05  |
|
MA(20): |
2.89 |
Signal(12,26,9): |
-0.07 |
|
MA(100): |
3.58 |
Stochastic Oscillator |
%K(14,3):
|
45.74 |
|
MA(250): |
4.50 |
%D(3): |
46.51 |
|
Average Volume(K) |
3-Month: |
3160
|
52-Week |
High:
|
11.65 |
|
10-Days: |
5201 |
Low: |
2.65 |
|
RSI |
RSI(14):
|
45.99 |
Change(%): |
-56.9 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-38.7 |
Shares Out. (M) |
10.38 |
|
EPS Est. Current Year |
-2.420 |
Return on Assets (ttm) |
-31.7 |
Shares Float (M) |
2.31 |
|
EPS Est. Next Year |
-2.950 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.770 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.40 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.810 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.52 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
0.00 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
0.00 |
P/CF |
0.00 |
|
|
|
|
|
|
